Comparative study of doxorubicin-loaded poly(lactide-co-glycolide) nanoparticles prepared by single and double emulsion methods

F. Tewes1, E. Munnier1, B. Antoon1, L. Ngaboni Okassa1, S. Cohen-Jonathan1, H. Marchais1, L. Douziech-Eyrolles1, M. Soucé1, P. Dubois1, I. Chourpa1
1Université François-Rabelais, Faculté de Pharmacie “Focalisation magnétique d’agents anticancéreux”, IFR 135, “Imagerie Fonctionnelle”, Tours, France

Tài liệu tham khảo

Ngaboni Okassa, 2007, Optimization of iron oxide nanoparticles encapsulation within poly(d,l-lactide-co-glycolide) sub-micron particles, Eur. J. Pharm. Biopharm. Lubbe, 2001, Clinical applications of magnetic drug targeting, J. Surg. Res., 95, 200, 10.1006/jsre.2000.6030 Sah, 1997, Microencapsulation techniques using ethyl acetate as a dispersed solvent: effects of its extraction rate on the characteristics of PLGA microspheres, J. Control. Release, 47, 233, 10.1016/S0168-3659(97)01647-7 Raghunand, 2003, Tumor acidity, ion trapping and chemotherapeutics. II. pH-dependent partition coefficients predict importance of ion trapping on pharmacokinetics of weakly basic chemotherapeutic agents, Biochem. Pharmacol., 66, 1219, 10.1016/S0006-2952(03)00468-4 Kataoka, 2000, Doxorubicin-loaded poly(ethylene glycol)-poly(beta-benzyl-l-aspartate) copolymer micelles: their pharmaceutical characteristics and biological significance, J. Control. Release, 64, 143, 10.1016/S0168-3659(99)00133-9 Anderson, 2002, Detection of doxorubicin and metabolites in cell extracts and in single cells by capillary electrophoresis with laser-induced fluorescence detection, J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 769, 97, 10.1016/S1570-0232(01)00633-X Gallois, 1996, The overall partitioning of anthracyclines into phosphatidyl-containing model membranes depends neither on the drug charge nor the presence of anionic phospholipids, Eur. J. Biochem., 241, 879, 10.1111/j.1432-1033.1996.00879.x Razzano, 1990, Determination of phenolic ionization constants of anthracyclines with modified substitution pattern of anthraquinone chromophore, IL Farmaco, 45, 215 Yoo, 2000, In vitro and in vivo anti-tumor activities of nanoparticles based on doxorubicin-PLGA conjugates, J. Control. Release, 68, 419, 10.1016/S0168-3659(00)00280-7 Némati, 1996, Reversion of multidrug resistance using nanoparticles in vitro: Influence of the nature of the polymer, Int. J. Pharm., 138, 237, 10.1016/0378-5173(96)04559-0